Clinical Trial Update: Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of PHP for treating shock associated with systemic inflammatory response syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shock
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• PHP

Snippet

Sponsor: Apex Bioscience | Conditions: Shock, Systemic Inflammatory Response Syndrome | Phase 3 | Status: COMPLETED